
106.47 Delayed Data As of Aug 12 | ![]() Today’s Change | 72.57 Today|||52-Week Range 169.98 | -31.07% Year-to-Date |
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 158.50, with a high estimate of 310.00 and a low estimate of 130.00. The median estimate represents a +48.87% increase from the last price of 106.47.
The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.